From January 1, 2024 to February 21, 2024, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 0 shares, representing 0% for $0 million under the buyback announced on February 23, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
80.09 USD | +1.32% |
|
+3.37% | +41.10% |
03/06 | Lemaitre Vascular, Inc. Announces Resignation of Lawrence J. Jasinski as A Director | CI |
31/05 | Roth MKM Upgrades LeMaitre Vascular to Buy Rating With $100 Price Target | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+41.10% | 179.77Cr | |
+7.77% | 22TCr | |
+10.16% | 19TCr | |
+26.21% | 15TCr | |
+32.78% | 11TCr | |
+1.98% | 6.4TCr | |
+14.48% | 5.26TCr | |
+2.92% | 4.99TCr | |
-6.60% | 3.79TCr | |
-1.07% | 3.49TCr |
- Stock Market
- Equities
- LMAT Stock
- News LeMaitre Vascular, Inc.
- Tranche Update on LeMaitre Vascular, Inc.'s Equity Buyback Plan announced on February 23, 2023.